STOCK TITAN

Outlook Therapeutics, Inc. (OTLK) Revenue by Year

OTLK

Outlook Therapeutics, Inc. generated $1.4M in revenue in fiscal year 2025. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Outlook Therapeutics, Inc. has filed alongside them.

FY2025 annual
Revenue $1.4M
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

OTLK Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Revenue$1.4MN/AN/AN/AN/AN/A$8.1M+163.8%$3.1M-19.0%$3.8M+27.9%$3.0M-42.9%$5.2M

OTLK Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Revenue$9K-99.4%$127KN/AN/A$1.5MN/AN/AN/AN/AN/AN/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Outlook Therapeutics, Inc. financials

Frequently Asked Questions

What was Outlook Therapeutics, Inc.'s revenue in fiscal year 2025?

Outlook Therapeutics, Inc. generated $1.4M in revenue in fiscal year 2025.

How has Outlook Therapeutics, Inc.'s revenue changed over the years?

Across the 11 fiscal years this page covers, Outlook Therapeutics, Inc. (OTLK) revenue went from $5.2M in fiscal year 2015 to $1.4M in fiscal year 2025.

What was Outlook Therapeutics, Inc.'s revenue in the most recent quarter?

Outlook Therapeutics, Inc. (OTLK) reported $9K in revenue in Q3 2026. This represents a decrease of 99.4% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Outlook Therapeutics, Inc. (OTLK) reported on that line in every period on record.